Semaglutide and Tirzepatide are often discussed together because both are used in modern metabolic and weight-management care, but they are not the same medication and they do not work in exactly the same way.
How Semaglutide Works
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone pathway involved in appetite, satiety, blood sugar regulation, and digestion. Depending on the specific FDA-approved product and indication, semaglutide may be prescribed for diabetes management or chronic weight management.
How Tirzepatide Works
Tirzepatide acts on both GIP and GLP-1 receptors. Like semaglutide, different branded products have different FDA-approved indications. Tirzepatide used for chronic weight management is prescribed under the appropriate FDA-approved product and indication.
Which One Is Better?
There is no single answer that applies to every patient. A physician may consider medical history, treatment goals, previous response to weight-loss medications, side effects, current medications, insurance or cost considerations, and other health factors before recommending one option over another.
The medication that produces the most attention online is not necessarily the best choice for a particular patient. The more useful question is: Which treatment is appropriate for your health, goals, and circumstances?
What About Side Effects?
Both medication classes can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort. Each product also has specific warnings and precautions that should be reviewed with a qualified medical professional before treatment.
For patients in Pasadena and Glendale, Medical Weight Loss and Beauty offers physician-supervised consultations to help determine whether Semaglutide, Tirzepatide, another treatment, or a non-medication approach may be appropriate.